Nanoparticle and targeted systems for cancer therapy

被引：1571

作者：

Brannon-Peppas, L ^{[1
]}

Blanchette, JO ^{[1
]}

机构：

[1] Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2004年 / 56卷 / 11期

关键词：

targeted delivery; nanoparticles; cancer therapy; angiogenesis; antibodies;

D O I：

10.1016/j.addr.2004.02.014

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

This review explores recent work directed towards more targeted treatment of cancer, whether through more specific anticancer agents or through methods of delivery. These areas include delivery by avoiding the reticuloendothelial system, utilizing the enhanced permeability and retention effect and tumor-specific targeting. Treatment opportunities using antibody-targeted therapies are summarized. The ability to treat cancer by targeting delivery through angiogenesis is also discussed and antiangiogenic drugs in clinical trials are presented. Delivery methods that specifically use nanoparticles are also highlighted, including both degradable and nondegradable polymers. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：1649 / 1659

页数：11

共 43 条

[1] An overview of targeted treatments in cancer
Abou-Jawde, R
Choueiri, T
Alemany, C
Mekhail, T
[J]. CLINICAL THERAPEUTICS, 2003, 25 (08) : 2121 - 2137
[2] Toward selection of internalizing antibodies from phage libraries
Becerril, B
Poul, MA
Marks, JD
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) : 386 - 393
[3] A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D
Bhadra, S
Jain, S
Jain, NK
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) : 111 - 124
[4] Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
Blessing, T
Kursa, M
Holzhauser, R
Kircheis, R
Wagner, E
[J]. BIOCONJUGATE CHEMISTRY, 2001, 12 (04) : 529 - 537
[5] Nanoparticles in cancer therapy and diagnosis
Brigger, I
Dubernet, C
Couvreur, P
[J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651
[6] Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
Chari, RVJ
[J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (1-2) : 89 - 104
[7] Targeting tumor angiogenesis with gene therapy
Chen, QR
Zhang, L
Gasper, W
Mixson, AJ
[J]. MOLECULAR GENETICS AND METABOLISM, 2001, 74 (1-2) : 120 - 127
[8] VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer:: in vivo studies
Dagar, S
Krishnadas, A
Rubinstein, I
Blend, MJ
Önyüksel, H
[J]. JOURNAL OF CONTROLLED RELEASE, 2003, 91 (1-2) : 123 - 133
[9] Tumour vasculature as a target for anticancer therapy
Eatock, MM
Schätzlein, A
Kaye, SB
[J]. CANCER TREATMENT REVIEWS, 2000, 26 (03) : 191 - 204
[10] Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases
Feng, SS
Chien, S
[J]. CHEMICAL ENGINEERING SCIENCE, 2003, 58 (18) : 4087 - 4114

← 1 2 3 4 5 →